Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Wagner

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Oncology|July 16, 2005
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancerAlberto Chiappori, George Simon, Charles Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397)Rafael Manon, Anne O'Neill, Jonathan Knisely, et al.
Frontiers in Oncology|December 16, 2014
The impact of protocol assignment for older adolescents with hodgkin lymphomaRichard S Pieters, Henry Wagner, Stephen Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394Stuart A Grossman, Anne O'Neill, Margaret Grunnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerDavid J Adelstein, Yi Li, George L Adams, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292)A Bapsi Chakravarthy, Paul J Catalano, James A Martenson, et al.
British Journal of Haematology|May 15, 2015
A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402Thomas E Witzig, Fangxin Hong, Ivana N Micallef, et al.
Clinical Genitourinary Cancer|February 16, 2016
Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and ReviewMhd Yaser Al-Marrawi, Heath B Mackley, Suhail Ali, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590Heather A Wakelee, Patricia Stephenson, Steven M Keller, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2004
Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 diseaseSteven M Keller, Mark G Vangel, Henry Wagner, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Oncology|July 16, 2005
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancerAlberto Chiappori, George Simon, Charles Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397)Rafael Manon, Anne O'Neill, Jonathan Knisely, et al.
Frontiers in Oncology|December 16, 2014
The impact of protocol assignment for older adolescents with hodgkin lymphomaRichard S Pieters, Henry Wagner, Stephen Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394Stuart A Grossman, Anne O'Neill, Margaret Grunnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerDavid J Adelstein, Yi Li, George L Adams, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292)A Bapsi Chakravarthy, Paul J Catalano, James A Martenson, et al.
British Journal of Haematology|May 15, 2015
A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402Thomas E Witzig, Fangxin Hong, Ivana N Micallef, et al.
Clinical Genitourinary Cancer|February 16, 2016
Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and ReviewMhd Yaser Al-Marrawi, Heath B Mackley, Suhail Ali, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590Heather A Wakelee, Patricia Stephenson, Steven M Keller, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2004
Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 diseaseSteven M Keller, Mark G Vangel, Henry Wagner, et al.
Pageof 5